Histopathological study of chronic hepatitis B and C: a comparison of two scoring systems

Rekha Rozario1, Banumathi Ramakrishna

  • 1Department of Pathology, Christian Medical College and Hospital, Vellore 632004, India.

Journal of Hepatology
|January 28, 2003
PubMed

Insights

The Ishak and METAVIR scoring systems show good agreement for necroinflammation and excellent agreement for fibrosis in chronic viral hepatitis patients. This aids in consistent histological assessment for liver disease.

Area of Science:

  • Hepatology
  • Histopathology
  • Virology

Background:

  • Chronic viral hepatitis diagnosis relies on histological scoring systems.
  • The Ishak (modified histological activity index, HAI) and METAVIR systems are commonly used.
  • Evaluating concordance between these systems is crucial for consistent patient management.

Purpose of the Study:

  • To assess the correlation between the Ishak and METAVIR scoring systems.
  • To evaluate these systems in Indian patients with chronic viral hepatitis B or C.
  • To compare histological features between hepatitis B virus (HBV) and hepatitis C virus (HCV) infections.

Main Methods:

  • Liver biopsies from 127 patients were scored using both Ishak and METAVIR systems.
  • Weighted kappa analysis was employed to determine correlation.
  • Serum transaminase levels and specific histological features were analyzed.

Main Results:

  • Moderate correlation (weighted kappa 0.627) was observed for necroinflammatory activity between Ishak and METAVIR.
  • Excellent correlation (weighted kappa 0.998) was found for fibrosis.
  • HCV biopsies showed significantly more micronodular cirrhosis, lymphoid aggregates, bile duct damage, bile ductular proliferation, and steatosis compared to HBV.

Conclusions:

  • The Ishak and METAVIR scoring systems demonstrate good concordance for assessing necroinflammatory changes.
  • Excellent agreement exists between the two systems for evaluating fibrotic changes in chronic viral hepatitis.
  • These findings support the interchangeable use of Ishak and METAVIR for fibrosis staging.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...